HBM Healthcare Investments (Cayman) Ltd. - Nov 9, 2021 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role
10%+ Owner
Signature
/s/ Jean-Marc LeSieur, Managing Director
Stock symbol
IOBT
Transactions as of
Nov 9, 2021
Transactions value $
$4,550,000
Form type
4
Date filed
11/12/2021, 03:16 PM
Previous filing
Nov 4, 2021
Next filing
Feb 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IOBT Common Stock Conversion of derivative security +2.37M 2.37M Nov 9, 2021 Direct F1
transaction IOBT Common Stock Purchase $4.55M +325K +13.74% $14.00 2.69M Nov 9, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOBT Series C Preferred Stock Conversion of derivative security $0 -188K -100% $0.00* 0 Nov 9, 2021 Common Stock 2.37M Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

HBM Healthcare Investments (Cayman) Ltd. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Upon the closing of the Issuer's initial public offering, each share of Series C Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into the number of shares of Common Stock reported in Column 7 of Table II. These shares of Series C Preferred Stock had no expiration date.